Relay Therapeutics, Inc. (RLAY) SEC Filings — 2025
9 SEC filings for Relay Therapeutics, Inc. (RLAY) in 2025.
Filings
- Relay Therapeutics Narrows Q3 Loss Amid R&D Cuts — 10-Q · Nov 6, 2025
- Relay Therapeutics' Q2 Net Loss Widens to $90.9M Amid R&D Surge — 10-Q · Aug 7, 2025
- Relay Therapeutics Appoints New Chief Medical Officer — 8-K · Jun 11, 2025
- Relay Therapeutics Files 8-K on Shareholder Votes — 8-K · Jun 6, 2025
- Relay Therapeutics Reports Material Agreements — 8-K · Jun 4, 2025
- Relay Therapeutics Files Q1 2025 10-Q — 10-Q · May 5, 2025
- Relay Therapeutics DEF 14A: Executive Compensation Details — DEF 14A · Apr 23, 2025
- Relay Therapeutics Files 2024 10-K, Reports on Offerings — 10-K · Feb 26, 2025
- Relay Therapeutics Files 8-K — 8-K · Jan 13, 2025